Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 1
2020 2
2021 5
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease.
Zobel CM, Kuhn H, Schreiner M, Wenzel W, Wendtland J, Goekeri C, Scheit L, Oltmanns K, Rauschning D, Grossegesse M, Hofmann N, Wirtz H, Spethmann S; BwKrhs-Covid-Research-Group. Zobel CM, et al. Among authors: grossegesse m. Virol J. 2024 Jan 10;21(1):15. doi: 10.1186/s12985-023-02283-w. Virol J. 2024. PMID: 38200555 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
Chasinga TB, Cikwanine JB, Kribi S, Yoyu JT, Hofmann N, Grossegesse M, Nitsche A, Tomczyk S, Vietor AC, Leendertz FH, Eckmanns T, Kusinza AB, Munguakonkwa E, Kalk A, Raha M, Kambale NS, Ayagirwe RB, Schubert G, Mukwege D. Chasinga TB, et al. Among authors: grossegesse m. BMJ Open. 2024 Jan 4;14(1):e072212. doi: 10.1136/bmjopen-2023-072212. BMJ Open. 2024. PMID: 38176860 Free PMC article.
A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity.
Stern D, Meyer TC, Treindl F, Mages HW, Krüger M, Skiba M, Krüger JP, Zobel CM, Schreiner M, Grossegesse M, Rinner T, Peine C, Stoliaroff-Pépin A, Harder T, Hofmann N, Michel J, Nitsche A, Stahlberg S, Kneuer A, Sandoni A, Kubisch U, Schlaud M, Mankertz A, Schwarz T, Corman VM, Müller MA, Drosten C, de la Rosa K, Schaade L, Dorner MB, Dorner BG. Stern D, et al. Among authors: grossegesse m. Sci Rep. 2023 Dec 9;13(1):21846. doi: 10.1038/s41598-023-48581-9. Sci Rep. 2023. PMID: 38071261 Free PMC article.
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.
Offergeld R, Preußel K, Zeiler T, Aurich K, Baumann-Baretti BI, Ciesek S, Corman VM, Dienst V, Drosten C, Görg S, Greinacher A, Grossegesse M, Haller S, Heuft HG, Hofmann N, Horn PA, Houareau C, Gülec I, Jiménez Klingberg CL, Juhl D, Lindemann M, Martin S, Neuhauser HK, Nitsche A, Ohme J, Peine S, Sachs UJ, Schaade L, Schäfer R, Scheiblauer H, Schlaud M, Schmidt M, Umhau M, Vollmer T, Wagner FF, Wieler LH, Wilking H, Ziemann M, Zimmermann M, der Heiden MA. Offergeld R, et al. Among authors: grossegesse m. Pathogens. 2023 Apr 2;12(4):551. doi: 10.3390/pathogens12040551. Pathogens. 2023. PMID: 37111436 Free PMC article.
Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study.
Stoliaroff-Pepin A, Peine C, Herath T, Lachmann J, Hellenbrand W, Perriat D, Dörre A, Nitsche A, Michel J, Grossegesse M, Hofmann N, Rinner T, Kohl C, Brinkmann A, Meyer T, Stern D, Treindl F, Dorner BG, Hein S, Werel L, Hildt E, Gläser S, Schühlen H, Isner C, Peric A, Ghouzi A, Reichardt A, Janneck M, Lock G, Huster D, Grünewald T, Schaade L, Wichmann O, Harder T. Stoliaroff-Pepin A, et al. Among authors: grossegesse m. Infection. 2023 Aug;51(4):1093-1102. doi: 10.1007/s15010-023-02012-z. Epub 2023 Mar 13. Infection. 2023. PMID: 36913112 Free PMC article.
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity.
Henze L, Braun J, Meyer-Arndt L, Jürchott K, Schlotz M, Michel J, Grossegesse M, Mangold M, Dingeldey M, Kruse B, Holenya P, Mages N, Reimer U, Eckey M, Schnatbaum K, Wenschuh H, Timmermann B, Klein F, Nitsche A, Giesecke-Thiel C, Loyal L, Thiel A. Henze L, et al. Among authors: grossegesse m. Front Immunol. 2023 Jan 31;14:1056525. doi: 10.3389/fimmu.2023.1056525. eCollection 2023. Front Immunol. 2023. PMID: 36798117 Free PMC article.
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.
Stoliaroff-Pepin A, Peine C, Herath T, Lachmann J, Perriat D, Dörre A, Nitsche A, Michel J, Grossegesse M, Hofmann N, Rinner T, Kohl C, Brinkmann A, Meyer T, Dorner BG, Stern D, Treindl F, Hein S, Werel L, Hildt E, Gläser S, Schühlen H, Isner C, Peric A, Ghouzi A, Reichardt A, Janneck M, Lock G, Schaade L, Wichmann O, Harder T. Stoliaroff-Pepin A, et al. Among authors: grossegesse m. Vaccine. 2023 Jan 9;41(2):290-293. doi: 10.1016/j.vaccine.2022.11.065. Epub 2022 Dec 2. Vaccine. 2023. PMID: 36509640 Free PMC article.
27 results